Nicolet Advisory Services’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-143
| Closed | -$2.82K | – | 354 |
|
|
2023
Q4 | $2.82K | Hold |
143
| – | – | ﹤0.01% | 320 |
|
|
2023
Q3 | $2.36K | Hold |
143
| – | – | ﹤0.01% | 315 |
|
|
2023
Q2 | $10.4K | Hold |
143
| – | – | ﹤0.01% | 308 |
|
|
2023
Q1 | $12.9K | Hold |
143
| – | – | ﹤0.01% | 283 |
|
|
2022
Q4 | $15.6K | Hold |
143
| – | – | ﹤0.01% | 239 |
|
|
2022
Q3 | $31K | Hold |
143
| – | – | 0.01% | 191 |
|
|
2022
Q2 | $30K | Hold |
143
| – | – | ﹤0.01% | 184 |
|
|
2022
Q1 | $11K | Hold |
143
| – | – | ﹤0.01% | 201 |
|
|
2021
Q4 | $23K | Hold |
143
| – | – | ﹤0.01% | 206 |
|
|
2021
Q3 | $39K | Hold |
143
| – | – | ﹤0.01% | 200 |
|
|
2021
Q2 | $57K | Hold |
143
| – | – | 0.01% | 186 |
|
|
2021
Q1 | $77K | Sell |
143
-7
| -5% | -$3.77K | 0.01% | 172 |
|
|
2020
Q4 | $57K | Hold |
150
| – | – | 0.01% | 172 |
|
|
2020
Q3 | $57K | Buy |
+150
| New | +$57K | 0.01% | 169 |
|